Clinical Trial

Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients

Name: Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients — clinical trial record (NCT07056439)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety and pharmacokinetics of HRS-1738 injection in adult patients with prostate cancer.

Trial Details

NCT Number	NCT07056439
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	PET Imaging in Patients With Prostate Cancer
Enrollment	50 participants
Start Date	2025-07
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2025-07-09